1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66C1FACB3D0201DEA00258CC80040DC1E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-maximizing-impact-infectious-disease-analytics-insights-teams-scaling-excellence-innovation-coes?opendocument
18
19opendocument
2018.97.9.174
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Field Medical Excellence (FME) Launch Services Excellence Patient Support Excellence Medical Operations Excellence Collections New Product Planning Medical Affairs

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Market Research, Analytics and Forecasting » Analytics

Maximizing the Impact of Infectious Disease Analytics and Insights Teams: Scaling Excellence with Advanced Analytics and Innovation CoEs

DB Image

Download FREE Excerpt

ID: 5887

Features:

19 Info Graphics

21 Data Graphics

780+ Metrics

16 Narratives

Pages/Slides: 47

Published: 2025

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Maximizing the Impact of Infectious Disease Analytics and Insights Teams: Scaling Excellence with Advanced Analytics and Innovation CoEs”

STUDY OVERVIEW

As infectious disease dynamics demand rapid insights and real-time analytics, A&I teams in this space must be at the forefront of data strategy and innovation. From tracking treatment patterns to supporting cross-functional responses during crises, advanced analytics and Centers of Excellence (CoEs) are critical tools in expanding the team’s impact.

This study by Best Practices, LLC offers a close look at how leading infectious disease A&I teams are leveraging high-end analytics, optimizing outsourcing partnerships, and contributing to innovation by collaborating with Centers of Excellence. It also explores the expanded use of analytics to inform both commercial and medical decisions.


KEY TOPICS

  • High-value analytics types, methodologies, platforms and outsourcing models
  • Streamlining market research through advanced analytics
  • Innovation centers of excellence: Usage, staffing, services and alignment

KEY METRICS

  • Analytic methodologies applied by Infectious Disease Analytics & Insights teams across operational areas
  • High-impact analytics projects supporting brand, HEOR, and other key internal partner teams
  • Insource vs. outsource approach for infectious disease analytics projects
  • Insource vs. outsource approach for specific methodologies and processes
  • Use of analytics as a substitute for market research in infectious disease
  • CoE penetration and alignment with infectious disease strategy
  • Relationship between innovation CoE (or similar department) and Analytics & Insights groups
  • Number of FTEs working in infectious disease-focused innovation CoEs or similar departments
  • Effective services delivered by innovation CoE (or similar groups) in supporting the overall organization
  • Critical background and skills required for staff working in an innovation CoE or similar department

SAMPLE KEY FINDINGS

  • A&I Methodologies Used: Commercial stakeholders are most often supported by infectious A&I groups, typically with visualization (80%), forecasting (80%), data mining (70%), and conjoint analysis (70%) activities. Fewer than 1/3 of internal clients (Corporate/brands, HEOR & Medical Affairs) are supported by these same analytics activities.

METHODOLOGY

Best Practices, LLC engaged 10 Analytics & Insights leaders from 10 leading biopharma organizations specializing in infectious diseases. The study provides segmentation by company size (mid vs. large pharma) and incorporates in-depth interviews for richer qualitative context. Notably, more than 20% of benchmark participants hold director-level or higher roles.

Industries Profiled:
Biotech; Pharmaceutical; Research; Consulting; Health Care; Diagnostic


Companies Profiled:
Bio-Rad Laboratories Inc.; Biotest AG; CSL Seqirus; Janssen; Lonza Inc.; MEDiSTRAVA; Merck; Qiagen; Takeda Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH